Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 603 48 263.5 |
| 96 | EP file number | EAKZ | 10 18 0486.2 |
| 97 | EP publication number | EPN | 2298278 |
| 54 | Designation/title | TI | Verhinderung und Reduzierung von Blutverlust und Entzündungsreaktion |
| 51 | IPC main class | ICM
(ICMV) | A61K 38/55 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61P 7/00 (2006.01), A61P 25/00 (2006.01) |
| 22 | DE application date | DAT | Jun 6, 2003 |
| 96 | EP application date | EAT | Jun 6, 2003 |
| 43 | Date of first publication | OT | Mar 23, 2011 |
| Date of publication of grant | PET | Nov 11, 2015 |
| 71/73 | Applicant/owner | INH | Takeda Pharmaceutical Company Limited, Osaka, JP |
| 72 | Inventor | IN | Ladner, Robert, Charles, Ijamsville, MD 21754, US; Ley, Arthur, C., Newton, MA 02465, US |
| 74 | Representative | VTR | LIPPERT STACHOW Patentanwälte Rechtsanwälte Partnerschaft mbB, 51427 Bergisch Gladbach, DE |
| Address for service | | LIPPERT STACHOW, 51412 Bergisch Gladbach, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
387239 P
Jun 7, 2002
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
407003 P
Aug 28, 2002
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002298278
Searchable text:
EP000002298278
Original document:
EP000002298278B1
Searchable text:
EP000002298278B1 |
| 43 | Date of first publication | EVT | Mar 23, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 8, 2023
(Show all update days)(Hide all update days)- May 27, 2011
- Date of the first transfer into DPMAregister
|
